Vries, S.H. de

prostate cancer prostate cancer patient screening study treatment biopsy survival disease european randomized study antigen diagnosis gleason surveillance follow-up erspc group j urol score european characteristic screen rotterdam randomized result volume table value progression psadt prostatectomy urology level stage death policy trial chapter therapy outcome analysis gleason score cohort mortality prostate-specific antigen schroder fh favourable tumour section prognostic range prostatic transabdominal section rotterdam detection serum difference prostate-specific psa level roobol mj number disease-specific survival eur urol prostate-speci fic antigen report vries sh change management grade 10 ng /ml criteria discussion rectal examination prostate volume reference schroder control transrectal favourable pca characteristics